Nutrition and Pregnancy Intervention Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

439 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized double-blind placebo controlled intervention study with pregnant obese women (n=440) will be conducted. The intervention will involve consumption of fish oil and/or probiotic capsules from early pregnancy until 6 months after delivery.

The aim of the study is firstly to investigate the effects of the supplements on the risk of gestational diabetes mellitus and obesity in the women and secondly to modify the risk markers of allergy and obesity in children of the women. Also the underlying metabolic mechanisms will be investigated.

Follow up visits at child's age of 5 to 6 years will be conducted to evalute long-term effects on maternal and child health. The aim is to investigate the impact of dietary intervention, diet, maternal overweight/obesity and gestational diabetes status as well as gut microbiota and metabolism during pregnancy on maternal and child's health, allergy and child neuropsychological development.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gestational Obesity and Interventions With Probiotics or Fish Oil Trial

NCT03215784

Obesity Pregnancy Inflammation

UNKNOWN NA

Fish Oil Supplementation in Women With Gestational Diabetes

NCT02371343

Fetal Macrosomia Congenital Abnormality Other Respiratory Problems After Birth

UNKNOWN NA

Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy

NCT00957476

Inflammation Obesity Pregnancy +1 more

COMPLETED NA

Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health

NCT02042274

Metabolic Syndrome X

COMPLETED NA

Effects of Omega-3 Fatty Acids on the Human Gene Expression

NCT01089231

Hyperlipidemia Healthy

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Obesity Gestational Diabetes Mellitus Adiposity Type2 Diabetes Cardiovascular Risk Factor Eating Behavior Liver Diseases Neurodevelopmental Disorders Cognitive Developmental Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic

Comparison of probiotics, fish oil and their combination to placebo

Group Type ACTIVE_COMPARATOR